Importance Dual antiplatelet therapy has been demonstrated to be superior to single
antiplatelet in reducing recurrent stroke among patients with transient ischemic attack or …

Background Dual antiplatelet treatment has been shown to lower the risk of recurrent stroke
as compared with aspirin alone when treatment is initiated early (≤ 24 hours) after an acute …

Abstract Background and Purpose The purpose of this study was to evaluate the association
between different antiplatelet therapy regimens and the functional outcomes and bleeding …

Background Recent clinical trials established the benefit of dual antiplatelet therapy with
aspirin and clopidogrel (DAPT‐AC) in early‐presenting patients with minor ischemic stroke …

Background A recent study shows that dual antiplatelet therapy with clopidogrel plus aspirin
is superior to aspirin monotherapy for minor stroke, which is defined as a National Institutes …

Importance Dual antiplatelet therapy with clopidogrel and aspirin is effective for secondary
prevention after minor ischemic stroke or transient ischemic attack (TIA). Uncertainties …

Background: This study compared the effectiveness of dual antiplatelet therapy (DAPT) with
clopidogrel-aspirin with that of aspirin monotherapy (AM) in mild-to-moderate acute ischemic …

Background No study has thoroughly compared the effectiveness of combined antiplatelet
treatments (other than clopidogrel–aspirin) versus clopidogrel–aspirin or aspirin alone for …

Background and Purpose—This study aimed to compare the effectiveness of dual
antiplatelet therapy with clopidogrel-aspirin to that of aspirin monotherapy in patients with …

Background and Purpose—This study aimed to compare the effectiveness of dual
antiplatelet therapy with clopidogrel plus aspirin (DAPT) with that of aspirin monotherapy …